Research programme: inflamation therapeutics - c-a-i-r biosciences
Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator c-a-i-r biosciences
- Class Small molecules
- Mechanism of Action 5-lipoxygenase-activating protein modulators; Cyclo-oxygenase 1 modulators; Cyclo-oxygenase 2 modulators; Interleukin 1 beta modulators; Protein kinase inhibitors; Tumour necrosis factor alpha modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-0 development in Inflammation in Germany